Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Alopecia Areata affects both patients and their cohabitants' quality of life and emotional well-being.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Ustekinumab helped three kids with alopecia areata regrow hair.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

ZIP10 is crucial for skin development and maintaining healthy skin.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Individual choice in treating alopecia areata greatly impacts quality of life.

CuATSM speeds up wound healing and reduces scarring.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

Zinc may help treat alopecia areata by boosting certain immune cells.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Apremilast improved symptoms in patients with severe skin conditions.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.